On June 8, 2020, Enochian Biosciences, Inc. issued a press release announcing the completion of an Initial Targeted Engagement for Regulatory Advice on CBER Products (INTERACT) meeting focused on Enochian’s ENOB-HV-01. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.
The information included in this Item 8.01 and in Exhibit 99.1 shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
ENOB
News 
Market Data 
Discover 
AI
